The N-Acylethanolamine-Mediated Regulatory Pathway in Plants

Aruna Kilaru; Elison B. Blancaflor; Barney J. Venables; Swati Tripathy; Kirankumar S. Mysore; Kent D. Chapman

The N-Acylethanolamine-Mediated Regulatory Pathway in Plants

Aruna Kilaru
, Elison B. Blancaflor
, Barney J. Venables
, Swati Tripathy
, Kirankumar S. Mysore
, Kent D. Chapman

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

BOOK SUMMARY: Originally a special issue of Chemistry & Biodiversity, the first part of this volume focuses on the plant Cannabis sativa, its active ingredients, and the discovery of cannabinoid receptors as well as the therapeutic applications of activating, or blocking, the receptors. Following an overview of the plant, its medicinal uses, and its preparations, further chapters cover biosynthetic pathways, pharmacological properties, cannabis-based medicine, toxicology, cannabis prohibition and clinical situations where blocking the cannabinoid receptors might be beneficial.

The second part covers the journey from humans to plants, analyzing anandamide, as well as other endocannabinoids and endocannabinoid congeners, biosynthetic pathways, current knowledge of FAAH-1, FAAH-2, monoglyceride lipase and NAAA, concluding with new areas of research.

Original language	American English
Title of host publication	Cannabinoids in Nature and Medicine
State	Published - Sep 28 2009

Disciplines

Biochemistry
Botany

Cite this

@inbook{453b04b2db90451ebe3ecb3d756aa81a,

title = "The N-Acylethanolamine-Mediated Regulatory Pathway in Plants",

abstract = " BOOK SUMMARY: Originally a special issue of Chemistry \& Biodiversity, the first part of this volume focuses on the plant Cannabis sativa, its active ingredients, and the discovery of cannabinoid receptors as well as the therapeutic applications of activating, or blocking, the receptors. Following an overview of the plant, its medicinal uses, and its preparations, further chapters cover biosynthetic pathways, pharmacological properties, cannabis-based medicine, toxicology, cannabis prohibition and clinical situations where blocking the cannabinoid receptors might be beneficial. The second part covers the journey from humans to plants, analyzing anandamide, as well as other endocannabinoids and endocannabinoid congeners, biosynthetic pathways, current knowledge of FAAH-1, FAAH-2, monoglyceride lipase and NAAA, concluding with new areas of research. ",

author = "Aruna Kilaru and Blancaflor, \{Elison B.\} and Venables, \{Barney J.\} and Swati Tripathy and Mysore, \{Kirankumar S.\} and Chapman, \{Kent D.\}",

year = "2009",

month = sep,

day = "28",

language = "American English",

booktitle = "Cannabinoids in Nature and Medicine",

}

TY - CHAP

T1 - The N-Acylethanolamine-Mediated Regulatory Pathway in Plants

AU - Kilaru, Aruna

AU - Blancaflor, Elison B.

AU - Venables, Barney J.

AU - Tripathy, Swati

AU - Mysore, Kirankumar S.

AU - Chapman, Kent D.

PY - 2009/9/28

Y1 - 2009/9/28

N2 - BOOK SUMMARY: Originally a special issue of Chemistry & Biodiversity, the first part of this volume focuses on the plant Cannabis sativa, its active ingredients, and the discovery of cannabinoid receptors as well as the therapeutic applications of activating, or blocking, the receptors. Following an overview of the plant, its medicinal uses, and its preparations, further chapters cover biosynthetic pathways, pharmacological properties, cannabis-based medicine, toxicology, cannabis prohibition and clinical situations where blocking the cannabinoid receptors might be beneficial. The second part covers the journey from humans to plants, analyzing anandamide, as well as other endocannabinoids and endocannabinoid congeners, biosynthetic pathways, current knowledge of FAAH-1, FAAH-2, monoglyceride lipase and NAAA, concluding with new areas of research.

AB - BOOK SUMMARY: Originally a special issue of Chemistry & Biodiversity, the first part of this volume focuses on the plant Cannabis sativa, its active ingredients, and the discovery of cannabinoid receptors as well as the therapeutic applications of activating, or blocking, the receptors. Following an overview of the plant, its medicinal uses, and its preparations, further chapters cover biosynthetic pathways, pharmacological properties, cannabis-based medicine, toxicology, cannabis prohibition and clinical situations where blocking the cannabinoid receptors might be beneficial. The second part covers the journey from humans to plants, analyzing anandamide, as well as other endocannabinoids and endocannabinoid congeners, biosynthetic pathways, current knowledge of FAAH-1, FAAH-2, monoglyceride lipase and NAAA, concluding with new areas of research.

M3 - Chapter

BT - Cannabinoids in Nature and Medicine

ER -